SIGMAR1 and Parkinson disease: In contrast to transgenic models of AD in vitro, AD and PD modeling by Aβ peptides or toxins, respectively, in most experiments is accompanied by an increase in BiP content while no induction or attenuation of Sigma1R expression is recorded (Figure 1, Figure 2, Figure 3 and Figure 4).